Summary
- Current Price
- As of today, LENZ price is $3.57, down -5.94% in the most recent trading session on
- Current Price All-Time High
- LENZ price is currently -92.93% below its historical high of $50.40 set on
- Market Cap
- LENZ current market cap is $112M, down -91.89% year-over-year
- Revenue
- LENZ current annual revenue is $19.09M, up +100.00% year-over-year
- Next Earnings
- The next earnings release for LENZ is on
Profile
| Metric | Value |
|---|---|
| Full Name | LENZ Therapeutics, Inc. |
| Ticker | NASDAQ: LENZ |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | lenz-tx.com |
| Employees | 152 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $3.57 | |
| Price, 1D Change | -5.94% | |
| $112M | ||
| - | ||
| - | ||
| 1.47 | ||
| $19.09M | ||
| Revenue, 1Y Change | +100.00% | |
| -$2.85 | ||
| EPS, 1Y Change | -21.88% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $1.03 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:7 | |
| Next Split | N/A | N/A |
| Last Ticker Change | GRPH | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.85 | ||
| EPS Estimate | -$4.25 | N/A |
| EPS Est. Change | -48.93% | N/A |
| $19.09M | ||
| Revenue Estimate | $16.99M | N/A |
| Revenue Est. Change | -10.99% | N/A |
| Current Price | $3.57 | |
| Price Target | $10.00 | - |
| Price Tgt. Change | +180.50% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.87 | -$2.34 | -24.76% | |
| -$2.58 | -$2.85 | -10.34% | |
| -$4.25 | N/A | -48.93% | |
| -$3.08 | N/A | -7.88% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $19.52M | $19.09M | -2.20% | |
| $16.99M | N/A | -10.99% | |
| $42.99M | N/A | +125.22% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $3.57 | |
| $9.41 | ||
| $4.82 | ||
| $10.46 | ||
| $4.83 | ||
| -$0.33 | ||
| 1.47 | ||
| $0.26 | ||
| 32.98 | ||
| 56.97% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $1.03 | |
| Upcoming | N/A | N/A |
| - | ||
| Total Dividend | - | |
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $19.09M | ||
| -$2.85 | ||
| $18.67M | ||
| 96.31% | ||
| -$91.14M | ||
| -477.46% | ||
| -$82.13M | ||
| -430.25% | ||
| -$90.85M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 14.23 | ||
| 14.09 | ||
| - | ||
| 3 | ||
| 2.26 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 5.22 | ||
| 0.51 | ||
| 0.79 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $284.34M | ||
| $292.35M | ||
| $305.88M | ||
| $301.41M | ||
| $21.54M | ||
| $21.19M | ||
| $815.00K | ||
| $465.00K | ||
| $4.17M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $101.22M | ||
| $109.81M | ||
| $418.00K | ||
| $0.00 | ||
| $287.00K | ||
| $0.00 | ||
| $502.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$69.17M | ||
| -$75.67M | ||
| $149.75M | ||
| $827.00K | ||
| -$70.00M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| Citigroup | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Citigroup | → | |
| B of A Securities | → | |
| Raymond James | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
No data
Screeners with LENZ
FAQ
- What is the ticker symbol for LENZ Therapeutics, Inc.?
- The ticker symbol for LENZ Therapeutics, Inc. is NASDAQ:LENZ
- Does LENZ Therapeutics, Inc. pay dividends?
- No, LENZ Therapeutics, Inc. does not pay dividends
- What sector is LENZ Therapeutics, Inc. in?
- LENZ Therapeutics, Inc. is in the Healthcare sector
- What industry is LENZ Therapeutics, Inc. in?
- LENZ Therapeutics, Inc. is in the Biotechnology industry
- What country is LENZ Therapeutics, Inc. based in?
- LENZ Therapeutics, Inc. is headquartered in United States
- When did LENZ Therapeutics, Inc. go public?
- LENZ Therapeutics, Inc. initial public offering (IPO) was on June 25, 2021
- Is LENZ Therapeutics, Inc. in the S&P 500?
- No, LENZ Therapeutics, Inc. is not included in the S&P 500 index
- Is LENZ Therapeutics, Inc. in the NASDAQ 100?
- No, LENZ Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is LENZ Therapeutics, Inc. in the Dow Jones?
- No, LENZ Therapeutics, Inc. is not included in the Dow Jones index
- When was LENZ Therapeutics, Inc. last earnings report?
- LENZ Therapeutics, Inc.'s most recent earnings report was on August 11, 2026
- When does LENZ Therapeutics, Inc. report earnings?
- The next expected earnings date for LENZ Therapeutics, Inc. is November 4, 2026
Data Sources & References
- LENZ Official Website www.lenz-tx.com
- LENZ Profile on Yahoo Finance finance.yahoo.com/quote/LENZ
- LENZ Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lenz